$715 million Bioelectronics Firm to be Created by GlaxoSmithKline and Alphabet
With the aim of creating a powerful new force in bioelectronics and use electrical signals rather than chemical or biological drugs to treat disease, GlaxoSmithKline has teamed up with Alphabet, Google’s holding company. With the ultimate aim of development of commercial bioelectronic medicines, Galvani Bioelectronics is being set up by GSK and Alphabet’s Verily Life Sciences —…









